Related content

Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma

By Jang Jeong   Park Young   Bae Si   Choi Jong   Yoon Seung   Chang U   Nam Soon   Kim Boo  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 5, 2004-11 ,pp. : 415-420

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck

By Katori Hideaki   Tsukuda Mamoru   Taguchi Takahide  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 6, 2007-06 ,pp. : 789-794

Springer Publishing Company

Access to resources Recommend Favorite

Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer

By Taeb J.   Artru P.   Baujat B.   Mabro M.   Carola E.   Maindrault F.   Tournigand C.   Krulik M.   Louvet C.   de Gramont A.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 661-666

Elsevier

Access to resources Recommend Favorite

Microvascular Invasion in Patients with Hepatocellular Carcinoma and Its Predictable Clinicopathological Factors

By Sumie Shuji  

Annals of Surgical Oncology, Vol. 15, Iss. 5, 2008-05 ,pp. : 1375-1382

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Benefit with Cisplatin, Hydroxyurea and 5-Fluorouracil/Leucovorin in Advanced Pancreatic Adenocarcinoma

By Raymond E.   de Gramont A.   Louvet C.   Tournigand C.   Demuynck B.   Beerblock K.   Carola E.   Krulik M.  

European Journal of Cancer, Vol. 33, Iss. 4, 1997-04 ,pp. : 696-697

Elsevier

Access to resources Recommend Favorite